Hello world!

Noradrenergic Mechanisms in Parkinson's Disease

Author: Mike Briley

Publisher: CRC Press

ISBN: 0849383919

Category: Science

Page: 288

View: 170

Download Now →

Noradrenergic Mechanisms in Parkinson's Disease examines fundamental and clinical evidence explaining the progression of the disease. Featuring contributions from acknowledged international experts in the field, this book defines ideopathic Parkinson's disease and covers such topics as the alterations in Parkinson's disease, norepinephrine-dopamine interactions, noradrenergic control of striatal dopamine release, glial cells as targets of the central noradrenergic systems, and a theory regarding noradrenergic mechanisms in Parkinson's disease. New directions for research on Parkinson's disease are also explored.
Noradrenergic Mechanisms in Parkinson's Disease
Language: en
Pages: 288
Authors: Mike Briley, M. Marien
Categories: Science
Type: BOOK - Published: 1993-12-16 - Publisher: CRC Press

Noradrenergic Mechanisms in Parkinson's Disease examines fundamental and clinical evidence explaining the progression of the disease. Featuring contributions from acknowledged international experts in the field, this book defines ideopathic Parkinson's disease and covers such topics as the alterations in Parkinson's disease, norepinephrine-dopamine interactions, noradrenergic control of striatal dopamine release, glial
Mechanisms in Parkinson's Disease
Language: en
Pages: 606
Authors: Juliana Dushanova
Categories: Medical
Type: BOOK - Published: 2012-02-08 - Publisher: IntechOpen

Parkinson's disease (PD) results primarily from the death of dopaminergic neurons in the substantia nigra. Current PD medications treat symptoms; none halt or retard dopaminergic neuron degeneration. The main obstacle to developing neuroprotective therapies is a limited understanding of the key molecular mechanisms that provoke neurodegeneration. The discovery of PD
Mechanisms in Parkinson's Disease
Language: en
Pages: 606
Authors: Juliana Dushanova
Categories: Medical
Type: BOOK - Published: 2012-02-08 - Publisher: BoD – Books on Demand

Parkinson's disease (PD) results primarily from the death of dopaminergic neurons in the substantia nigra. Current PD medications treat symptoms; none halt or retard dopaminergic neuron degeneration. The main obstacle to developing neuroprotective therapies is a limited understanding of the key molecular mechanisms that provoke neurodegeneration. The discovery of PD
The Role of Norepinephrine in Vocal Communication and Anxiety in Parkinson Disease
Language: en
Pages: 175
Authors: Jesse Hoffmeister
Categories: Medical
Type: BOOK - Published: 2021 - Publisher:

Vocal communication impairment and anxiety are co-occurring and interacting signs of Parkinson Disease (PD) that are common, poorly understood, and under-treated. Both vocal communication and anxiety are influenced by the locus coeruleus noradrenergic system. In light of this shared neural substrate and considering that noradrenergic dysfunction is a defining characteristic
Glutathione In The Nervous System
Language: en
Pages: 389
Authors: Christopher Ari Shaw
Categories: Science
Type: BOOK - Published: 1998-02-27 - Publisher: CRC Press

The goal of this text is to focus readers attention on three major areas; the origin and localization of GSH in the nervous system; the multiple effects of GSH on neural health activity; and the potential for alterations on GSH status to lead to neurological damage of the type observed